4.7 Article

Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells

期刊

MOLECULAR CANCER
卷 12, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1476-4598-12-50

关键词

CLL; microRNA; STAT3

资金

  1. MD Anderson Cancer Center Support Grant [CA016672]

向作者/读者索取更多资源

Backgrounds: Approximately 1,000 microRNAs (miRs) are present in the human genome; however, little is known about the regulation of miR transcription. Because miR levels are deregulated in chronic lymphocytic leukemia (CLL) and signal transducer and activator of transcription (STAT)-3 is constitutively activated in CLL, we sought to determine whether STAT3 affects the transcription of miR genes in CLL cells. Methods: We used publically available data from the ENCODE project to identify putative STAT3 binding sites in the promoters of miR genes. Then we transfected CLL cells with STAT3-shRNA or with an empty vector, and to determine which miRs are differentially expressed, we used a miR microarray approach followed by validation of the microarray results for 6 miRs using quantitative real-time polymerase chain reaction (qRT-PCR). Results: We identified putative STAT3 binding sites in 160 promoter regions of 200 miRs, including miR-21, miR-29, and miR-155, whose levels have been reported to be upregulated in CLL. Levels of 72 miRs were downregulated (n = 63) or upregulated (n = 9). qRT-PCR confirmed the array data in 5 of 6 miRs. Conclusions: The presence of activated STAT3 has a profound effect on miR expression in CLL cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Effects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies

Fabiana Tortora, George A. Calin, Amelia Cimmino

Summary: Non-coding RNAs, especially long ncRNAs, play a crucial role in cancer progression by influencing physiological processes, particularly in genitourinary neoplasms. Their dysregulation can be significant for cancer onset and progression.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

JAM-ming miR-21

Swati Mohapatra, George Calin

CELL DEATH AND DIFFERENTIATION (2021)

Article Biotechnology & Applied Microbiology

Noncoding RNA therapeutics - challenges and potential solutions

Melanie Winkle, Sherien M. El-Daly, Muller Fabbri, George A. Calin

Summary: In recent years, RNA-based therapies have gained FDA approval, but there are still challenges in targeting ncRNAs. Therapeutic targeting of noncoding RNAs has the potential to become a new approach for treating diseases such as cancer.

NATURE REVIEWS DRUG DISCOVERY (2021)

Editorial Material Oncology

Standardisation of protocols can be crucial in long non-coding RNA research

Kinga Nemeth, George A. Calin

Summary: The article reviews the current knowledge about the role of circular and linear forms of PVT1 non-coding RNA in cancer and human diseases, highlighting technical challenges and potential biases in publications that researchers need to pay more attention to.

BRITISH JOURNAL OF CANCER (2022)

Review Biochemistry & Molecular Biology

Non-coding RNAs and ferroptosis: potential implications for cancer therapy

Amar Balihodzic, Felix Prinz, Michael A. Dengler, George A. Calin, Philipp J. Jost, Martin Pichler

Summary: Ferroptosis is a distinct form of regulated cell death that differs from traditional programmed cell death. It is associated with various cellular signaling pathways and molecules, and alterations in the ferroptosis-regulating network can contribute to the development of diseases, including cancer. Suppression of ferroptosis is common in cancer cells, allowing them to survive and progress. However, cancer cells resistant to common chemotherapeutic drugs are highly susceptible to ferroptosis inducers, suggesting the potential of targeting ferroptosis for cancer treatment. Non-coding RNAs (ncRNAs) play a crucial role in regulating ferroptosis in cancer and hold promise as therapeutic targets.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with Oncogene-Addicted Advanced Lung Adenocarcinoma: A Real-World Clinical Study

Laura Lupini, Roberta Roncarati, Lorenzo Belluomini, Federica Lancia, Cristian Bassi, Lucilla D'Abundo, Angelo Michilli, Paola Guerriero, Alessandra Fasano, Elisa Tiberi, Andrea Salamone, Donato Michele Cosi, Elena Saccenti, Valentina Tagliatti, Iva Maestri, Silvia Sabbioni, Stefano Volinia, Roberta Gafa, Giovanni Lanza, Antonio Frassoldati, Massimo Negrini

Summary: This study evaluated the usefulness of liquid biopsy in the clinical management of advanced-stage oncogene-addicted non-small-cell lung adenocarcinomas. The results showed that liquid biopsy could detect disease progression earlier and identify new mutations responsible for treatment resistance. The study provided algorithms for the use of liquid biopsy in diagnosis and therapy monitoring.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

miRacle of microRNA-Driven Cancer Nanotherapeutics

Goknur Kara, Banu Arun, George A. Calin, Bulent Ozpolat

Summary: The discovery of microRNAs has revolutionized cancer treatment and their effective and safe delivery remains a challenge. New nanoparticle-based carriers have enabled successful tumor-targeted delivery of miRNA therapeutics, accelerating the transition of miRNAs from the lab to the bedside.

CANCERS (2022)

Review Oncology

Emerging role of oncogenic long noncoding RNA as cancer biomarkers

Marianna Aprile, Valerio Costa, Amelia Cimmino, George Adrian Calin

Summary: The view of long noncoding RNAs as nonfunctional garbage has been outdated, as evidence suggests their role as golden junk, particularly in precision oncology. They have potential use as diagnostic and/or prognostic biomarkers, and advancements in technology have made it easier to profile them in multiple tumors and large cohorts.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Contributions of Circulating microRNAs for Early Detection of Lung Cancer

Jody Vykoukal, Johannes F. Fahrmann, Nikul Patel, Masayoshi Shimizu, Edwin J. Ostrin, Jennifer B. Dennison, Cristina Ivan, Gary E. Goodman, Mark D. Thornquist, Matt J. Barnett, Ziding Feng, George A. Calin, Samir M. Hanash

Summary: Blood-based cancer biomarkers, including miRNA and four protein marker panel, have shown utility in improving the assessment and early detection of lung cancer.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Lnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer

Ana Carolina Rodrigues, Erika Pereira Zambalde, Daniel de Lima Bellan, Edvaldo da Silva Trindade, Enilze Maria de Souza Fonseca Ribeiro, George Calin, Daniela Fiori Gradia, Jaqueline Carvalho de Oliveira

Summary: This study aimed to investigate the role of long non-coding RNA lnc-uc.147 in different types of cancer and suggest its functional and regulation aspects. The results showed that deregulated expression of lnc-uc.147 was associated with histologic grade in hepatocellular carcinoma and tumor stage in clear cell renal and gastric adenocarcinoma. Silencing lnc-uc.147 reduced the viability and clonogenic capacity of HepG2 cell lines. Additionally, a relationship between the transcription factor TEAD4 and lnc-uc.147 was suggested in liver and breast cancer cells.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Artificial miRNAs derived from miR-181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs

Sergiu Chira, Cristina Ciocan, Cecilia Bica, George A. Calin, Ioana Berindan-Neagoe

Summary: miRNAs are noncoding RNAs that regulate genes and play a key role in cell homeostasis. The interaction between miRNAs and their target mRNAs is believed to depend on sequence complementarity, but some evidence suggests that miRNAs can adopt different structures that affect their function. By studying the oncogenic miR-181 family, we propose that the primary sequence and secondary structure of miRNAs may impact the number and range of targeted cellular transcripts. We also highlight that specific changes in miR-181 primary sequences may limit target gene selection and lead to the targeting of new transcripts with enhanced cancer-related functions.

FEBS LETTERS (2023)

Review Biochemistry & Molecular Biology

Going circular: history, present, and future of circRNAs in cancer

Giuseppina Pisignano, David C. Michael, Tanvi H. Visal, Radu Pirlog, Michael Ladomery, George A. Calin

Summary: To date, thousands of circRNAs, which are highly abundant and conserved single-stranded RNA molecules shaped into ring structures, have been identified. CircRNAs have been shown to regulate gene expression and exhibit tissue- and development-specific expression patterns associated with normal and disease conditions, including cancer. They have drawn attention as potential diagnostic and prognostic biomarkers in cancer due to their stability and resistance to ribonucleases. However, their circular shape limits their annotation and a complete understanding of their functions is still lacking, making their detection and biomedical application challenging.

ONCOGENE (2023)

Review Genetics & Heredity

Non-coding RNAs in disease: from mechanisms to therapeutics

Kinga Nemeth, Recep Bayraktar, Manuela Ferracin, George A. Calin

Summary: Non-coding RNAs (ncRNAs) are a group of transcripts that are not translated into proteins. They play important roles in regulating biological functions and are implicated in disease. In this review, the authors summarize the roles of miRNAs, lncRNAs, and circRNAs in cancer and other major human diseases, and discuss their potential as biomarkers and therapeutic targets.

NATURE REVIEWS GENETICS (2023)

Review Biochemistry & Molecular Biology

Targeting non-coding RNAs to overcome cancer therapy resistance

BaoQing Chen, Mihnea P. Dragomir, Chen Yang, Qiaoqiao Li, David Horst, George A. Calin

Summary: Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play a crucial role in regulating resistance to different cancer therapies by rewiring essential signaling pathways. ncRNAs have the potential to serve as biomarkers for predicting and detecting resistance to treatment, and targeting ncRNAs may be a strategy to overcome cancer treatment resistance.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth

Caitrin Crudden, Takashi Shibano, Dawei Song, Mihnea P. Dragomir, Sonia Cismas, Julianna Serly, Daniela Nedelcu, Enrique Fuentes-Mattei, Andrei Tica, George A. Calin, Ada Girnita, Leonard Girnita

Summary: This study elucidates the molecular and biological roles of biased signaling downstream RTK, providing a novel approach to enhance the efficacy of anti-IGF1R-targeted therapy in cancer by targeting system bias. The findings suggest a promising strategy for the rational design or repurposing of therapeutics to selectively cross-target the IGF1R or other RTK.

CANCER RESEARCH (2021)

暂无数据